Personalis, Inc. (PSNL)

NasdaqGM • Currently up 0.05 (+0.32%) in today's trading session

2 members of Congress have disclosed 19 trades in Personalis, Inc. (PSNL) via STOCK Act filings. The most recent disclosure was a sale by Brian J. Mast on 19 May 2020. The most active traders have been Brian J. Mast (15) and Brian Mast (4). Aggregate disclosed activity totals roughly $194.5K in purchases and $202.5K in sales (midpoint estimates from bracketed disclosure amounts).

Personalis, Inc. is currently trading at $15.90, positioned at 79% of its 52-week range ($4.96 – $18.89).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$15.90
24h Change
+0.05 (+0.32%)
52 Week Range
$4.96–$18.89
View on NASDAQ

Personalis, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PSNL

Select to highlight on chart
5 transactions
Compliance: 16%
Brian J. Mast19 May 20204 Jun 2020SaleStock$15,001 - $50,000N/A
Brian J. Mast19 May 20206 Oct 2022SaleStock$15,001 - $50,000N/A
Brian J. Mast19 May 202011 Jul 2022SaleStock$15,001 - $50,000N/A
Brian J. Mast19 May 202030 Jul 2021SaleStock$15,001 - $50,000N/A
Brian Mast19 May 202011 Jan 2023SaleStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.7B

Volume

3.26M

Beta

2.32

P/E Ratio

-14.59

Fundamentals

EPS

$-1.09

Div. Yield

-

Open

$15.78

Day Range

$15.68 – $16.00

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Christopher Hall
IPO Date
2019-06-20
Website
www.personalis.com

Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic rese...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$-0.26

Rev. Est.

$21.5M

Days Until

19

Recent Quarters

Q2 20264 Aug
EPS$-0.30
Miss 13.9%
Q1 20267 May
EPS$-0.29
Miss 26.1%
Q4 202526 Feb
EPS$-0.26
Beat 16.1%
Q3 20254 Nov
EPS$-0.24
Beat 14.3%
Q2 20255 Aug
EPS$-0.23
Beat 8.0%
Q1 20256 May
EPS$-0.18
Beat 21.7%
Q4 202427 Feb
EPS$-0.23
Beat 28.1%
Q3 20246 Nov
EPS$-0.64
Miss 93.9%
Q2 20247 Aug
EPS$-0.24
Beat 29.4%
Q1 20248 May
EPS$-0.26
Beat 40.9%
Q4 202328 Feb
EPS$-0.46
Beat 13.2%
Q3 20237 Nov
EPS$-0.51
Beat 5.6%
Q2 20238 Aug
EPS$-0.50
Beat 10.7%
Q1 20233 May
EPS$-0.61
Beat 1.6%
Q4 202223 Feb
EPS$-0.67
Miss 3.1%
Q3 20222 Nov
EPS$-0.58
Beat 7.9%
Q2 20223 Aug
EPS$-0.60
Beat 4.8%
Q1 20224 May
EPS$-0.63
Miss 10.5%
Q4 202124 Feb
EPS$-0.45
Beat 11.8%
Q3 20214 Nov
EPS$-0.40
Beat 0.0%
Q2 20214 Aug
EPS$-0.34
Beat 12.8%
Q1 20215 May
EPS$-0.29
Beat 21.6%
Q4 202025 Feb
EPS$-0.34
Miss 13.3%
Q3 20205 Nov
EPS$-0.27
Beat 10.0%
Q2 20206 Aug
EPS$-0.29
Beat 14.7%
Q1 20207 May
EPS$-0.29
Miss 11.5%
Q4 201925 Mar
EPS$-0.21
Beat 19.2%
Q3 201913 Nov
EPS$-0.22
Beat 12.0%
Q2 201913 Aug
EPS$-0.89
Miss 187.1%
Q1 201920 Jun
EPS$-0.16
Q4 201831 Mar
EPS$-0.20
Q2 201830 Sept
EPS$-0.17
Q1 201830 Jun
EPS$-0.34
Q4 201731 Mar
EPS$-0.25

5 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CVS

CVS Health Corporation

47
$90.39+2.84 (+3.24%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

EXPE

Expedia Group, Inc.

20
$274.69+1.25 (+0.46%)
Consumer Cyclical
Held by same politician
Significant holdings value
1 politician
View Stock

UBER

Uber Technologies, Inc.

17
$69.29-2.03 (-2.85%)
Technology
Held by same politician
1 politician
View Stock

Frequently Asked Questions about PSNL

Which members of Congress have traded PSNL?
2 members of Congress have disclosed 19 trades in Personalis, Inc. (PSNL) under the STOCK Act. The most active traders are Brian J. Mast and Brian Mast.
When was PSNL most recently disclosed by Congress?
The most recent PSNL disclosure was a sale by Brian J. Mast on 19 May 2020.
What is the total disclosed congressional trading volume for PSNL?
Members of Congress have disclosed approximately $194.5K in PSNL purchases and $202.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in PSNL?
This PSNL page updates as soon as new STOCK Act disclosures are filed for Personalis, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.